Spironolactone and conivaptan (DrugBank: Spironolactone, Conivaptan)
7 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
58 | 肥大型心筋症 | 0 |
67 | 多発性嚢胞腎 | 0 |
86 | 肺動脈性肺高血圧症 | 1 |
113 | 筋ジストロフィー | 0 |
210 | 単心室症 | 0 |
218 | アルポート症候群 | 0 |
225 | 先天性腎性尿崩症 | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00811486 (ClinicalTrials.gov) | January 2009 | 18/12/2008 | Body Volume Regulation in Pulmonary Arterial Hypertension With Right Ventricular Failure | Body Volume Regulation in Pulmonary Arterial Hypertension With Right Ventricular Failure | Right Heart Failure;Pulmonary Hypertension | Drug: Spironolactone and conivaptan | University of Colorado, Denver | NULL | Withdrawn | 18 Years | 75 Years | Both | 0 | N/A | United States |